A Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEDI1814 in Subjects with Mild to Moderate Alzheimers Disease

Grants and Contracts Details

StatusFinished
Effective start/end date12/10/14 → 12/31/16

Funding

  • Parexel International Co: $2.00